Research map: Suppression of AAV-Delivered Transgene Expression Using Artificial MicroRNAs Delivered by an Alternative AAV Serotype

Back to the article

Papers in this map

  1. miRDB: an online database for prediction of functional microRNA targets · Yuhao Chen · 2019 · 3587 citations · Cited by this paper
  2. Retroviral Transduction of Human CD4 + T Cells with Membrane-Attached IL-10 Generates Type 1-Like Regulatory T Cells · 2026 · Related
  3. Adeno-associated virus vector as a platform for gene therapy delivery · Dan Wang · 2019 · 2488 citations · Cited by this paper
  4. Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors · 2026 · Related
  5. Adeno-Associated Virus (AAV) as a Vector for Gene Therapy · Michael F. Naso · 2017 · 1403 citations · Cited by this paper
  6. Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys ( Macaca mulatta ) · 2026 · Related
  7. Engineering adeno-associated virus vectors for gene therapy · Chengwen Li · 2020 · 1209 citations · Cited by this paper
  8. High Prevalence of Preexisting Neutralizing Antibodies Against Adeno-Associated Virus Capsids in Mongolian People with Hemophilia · 2026 · Related
  9. RNAi therapeutics: Principles, prospects and challenges · Lars Aagaard · 2007 · 896 citations · Cited by this paper
  10. Quantification of Lentiviral Vectors with Nucleic Acid Dyes · 2026 · Related
  11. Emerging Issues in AAV-Mediated In Vivo Gene Therapy · Pasqualina Colella · 2017 · 893 citations · Cited by this paper
  12. CAR-T Cell Therapy: Manufacturing Platforms and Clinical Consequences · 2026 · Related
  13. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN · Christian J. Hinderer · 2018 · 833 citations · Cited by this paper
  14. A Review of the Challenge of Pre-Existing Humoral Immunity in Adeno-Associated Virus Gene Therapy and Potential Solutions · 2026 · Related
  15. Current Clinical Applications of In Vivo Gene Therapy with AAVs · Jerry R. Mendell · 2020 · 767 citations · Cited by this paper
  16. Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases · 2026 · Related
  17. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi · Jodi L. McBride · 2008 · 618 citations · Cited by this paper
  18. Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing · 2026 · Related
  19. CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors · Dan Wang · 2020 · 546 citations · Cited by this paper
  20. Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heart · 2025 · Related
  21. The clinical landscape for AAV gene therapies · Dmitry Kuzmin · 2021 · 522 citations · Cited by this paper
  22. Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo · Ryan L. Boudreau · 2008 · 360 citations · Cited by this paper
  23. High-dose AAV gene therapy deaths · 2020 · 259 citations · Cited by this paper
  24. Intracellular transport of recombinant adeno-associated virus vectors · Mathieu E. Nonnenmacher · 2012 · 257 citations · Cited by this paper
  25. An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery · Qin Huang · 2024 · 194 citations · Cited by this paper
  26. MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates · Juliette Hordeaux · 2020 · 180 citations · Cited by this paper
  27. A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo · Guocai Zhong · 2019 · 115 citations · Cited by this paper
  28. Dosage Thresholds and Influence of Transgene Cassette in Adeno-Associated Virus–Related Toxicity · Hanen Khabou · 2018 · 102 citations · Cited by this paper
  29. Host determinants of adeno-associated viral vector entry · Sirika Pillay · 2017 · 99 citations · Cited by this paper
  30. The regulatory impact of RNA-binding proteins on microRNA targeting · Sukjun Kim · 2021 · 96 citations · Cited by this paper
  31. Enzyme/Prodrug Systems for Cancer Gene Therapy · Obeid M. Malekshah · 2016 · 92 citations · Cited by this paper
  32. Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis · Phil Lieberman · 2012 · 76 citations · Cited by this paper
  33. High Levels of Frataxin Overexpression Lead to Mitochondrial and Cardiac Toxicity in Mouse Models · Brahim Belbellaa · 2020 · 74 citations · Cited by this paper
  34. Development of a Liver-specific Tet-On Inducible System for AAV Vectors and Its Application in the Treatment of Liver Cancer · Lucía Vanrell · 2011 · 63 citations · Cited by this paper
  35. Revisiting the “New” Inflammatory Toxicities of Adeno-Associated Virus Vectors · Terence R. Flotte · 2020 · 56 citations · Cited by this paper
  36. Synthetic Biology: Emerging Concepts to Design and Advance Adeno‐Associated Viral Vectors for Gene Therapy · Hanna J. Wagner · 2021 · 51 citations · Cited by this paper
  37. Delivering AAV to the Central Nervous and Sensory Systems · Cole W. Peters · 2021 · 47 citations · Cited by this paper
  38. Short Hairpin RNAs for Strand-Specific Small Interfering RNA Production · Peike Sheng · 2020 · 46 citations · Cited by this paper
  39. Improved knockdown from artificial microRNAs in an enhanced miR-155 backbone: a designer's guide to potent multi-target RNAi · Daniel K. Fowler · 2015 · 39 citations · Cited by this paper

Source: OpenAlex (CC0)